GB0214147D0
(en)
*
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Formulations
|
AU2003258327B2
(en)
*
|
2002-08-23 |
2009-05-21 |
Pharmacia Corporation |
Crystalline solid form of (2S-5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
PE20060272A1
(en)
|
2004-05-24 |
2006-05-22 |
Glaxo Group Ltd |
(2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
EP1841780B1
(en)
|
2005-01-10 |
2011-07-27 |
Glaxo Group Limited |
Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
PE20100741A1
(en)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPOUNDS DERIVED FROM 3,4-DIHYDROPYRIMIDE [4,5-d] PYRIMIDIN-2 (1H) -ONE AS KINASE INHIBITORS p38
|
TWI389690B
(en)
|
2005-03-25 |
2013-03-21 |
Glaxo Group Ltd |
Novel compounds
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
TW200730498A
(en)
|
2005-12-20 |
2007-08-16 |
Glaxo Group Ltd |
Compounds
|
US7943651B2
(en)
|
2006-04-20 |
2011-05-17 |
Glaxo Group Limited |
Compounds
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
SI2046787T1
(en)
|
2006-08-01 |
2011-07-29 |
Glaxo Group Ltd |
PYRAZOLO?á3,4-B?åPYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS
|
US20080114021A1
(en)
*
|
2006-11-09 |
2008-05-15 |
University Of Maryland Baltimore |
Use Of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antimicrobial Agent
|
AR065804A1
(en)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
|
MX2010012814A
(en)
|
2008-05-23 |
2010-12-20 |
Amira Pharmaceuticals Inc |
5-lipoxygenase-activating protein inhibitor.
|
ES2383246T3
(en)
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
ES2566339T3
(en)
|
2008-06-05 |
2016-04-12 |
Glaxo Group Limited |
4-Carboxamide indazole derivatives useful as PI3-kinase inhibitors
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
WO2010102958A1
(en)
|
2009-03-09 |
2010-09-16 |
Glaxo Group Limited |
4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
|
EP2406249A1
(en)
|
2009-03-10 |
2012-01-18 |
Glaxo Group Limited |
Indole derivatives as ikk2 inhibitors
|
WO2010106016A1
(en)
|
2009-03-17 |
2010-09-23 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|
EP2408458A1
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
EP2408915A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
MX2011009724A
(en)
|
2009-03-19 |
2011-10-14 |
Merck Sharp & Dohme |
RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING.
|
EP2408916A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
EP2411520A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
JP2012521765A
(en)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
RNA interference-mediated inhibition of intracellular adhesion molecule 1 (ICAM-1) gene expression using small interfering nucleic acids (siNA)
|
US20120004281A1
(en)
|
2009-03-27 |
2012-01-05 |
Merck Sharp & Dohme Corp |
RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
WO2010111464A1
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20100273744A1
(en)
|
2009-04-24 |
2010-10-28 |
Paul Martin Gore |
Compounds
|
WO2010122088A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
BRPI1016219B8
(en)
|
2009-04-30 |
2021-05-25 |
Glaxo Group Ltd |
indazole compound substituted with oxazole, and pharmaceutical composition
|
WO2011067366A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
JP2013512879A
(en)
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Benzpyrazole derivatives as inhibitors of PI3 kinase
|
EP2512438B1
(en)
|
2009-12-16 |
2017-01-25 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
TWI375671B
(en)
*
|
2010-03-01 |
2012-11-01 |
Univ China Medical |
Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
PL2614058T3
(en)
|
2010-09-08 |
2015-12-31 |
Glaxosmithkline Ip Dev Ltd |
POLYMORPHS AND SALTS OF N-[5-[4-(5-{[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]METHYL}-& xA;1,3-OXAZOL-2-YL)-1H-INDAZOL-6-YL]-2-(METHYLOXY)-3-PYRIDINYL]METHANESULFONAMIDE
|
ES2602972T3
(en)
|
2010-09-08 |
2017-02-23 |
Glaxosmithkline Intellectual Property Development Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
ES2532213T3
(en)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Pyrazole compounds that act against allergic, immune and inflammatory conditions
|
WO2012052459A1
(en)
|
2010-10-21 |
2012-04-26 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
JP2012140390A
(en)
*
|
2011-01-06 |
2012-07-26 |
Sumitomo Chemical Co Ltd |
METHOD FOR PRODUCING α-AMINO-γ-BUTYROLACTONE
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
EP2683716A1
(en)
|
2011-03-11 |
2014-01-15 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
CN102344397B
(en)
*
|
2011-08-23 |
2013-09-04 |
浙江升华拜克生物股份有限公司 |
Method for purifying valnemulin hydrochloride
|
KR20160060100A
(en)
|
2013-09-22 |
2016-05-27 |
칼리토르 사이언시즈, 엘엘씨 |
Substituted aminopyrimidine compounds and methods of use
|
EP3122730B1
(en)
|
2014-03-28 |
2020-03-25 |
Calitor Sciences, LLC |
Substituted heteroaryl compounds and methods of use
|
WO2015173701A2
(en)
|
2014-05-12 |
2015-11-19 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions for treating infectious diseases
|
EP3347097B1
(en)
|
2015-09-11 |
2021-02-24 |
Sunshine Lake Pharma Co., Ltd. |
Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora
|
WO2017214159A1
(en)
|
2016-06-06 |
2017-12-14 |
The Regents Of The University Of California |
A host cell modified to produce lactams
|
WO2019099311A1
(en)
|
2017-11-19 |
2019-05-23 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
EP3740468A4
(en)
|
2018-01-20 |
2021-10-06 |
Sunshine Lake Pharma Co., Ltd. |
Substituted aminopyrimidine compounds and methods of use
|
CN109369432B
(en)
*
|
2018-11-02 |
2021-06-25 |
永农生物科学有限公司 |
Preparation method of (S) -4-chloro-2-aminobutyrate
|
EP4125919A1
(en)
|
2020-03-26 |
2023-02-08 |
GlaxoSmithKline Intellectual Property Development Limited |
Cathepsin inhibitors for preventing or treating viral infections
|